NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-162-2016-0-PT-25 GENE THERAPY FOR RETINITIS PIGMENTOSA PT EP 15825383.1 Issued
NEI E-162-2016-0-ES-16 GENE THERAPY FOR RETINITIS PIGMENTOSA ES EP 15825383.1 Issued
NEI E-162-2016-0-MT-31 GENE THERAPY FOR RETINITIS PIGMENTOSA MT EP 15825383.1 Issued
NEI E-162-2016-0-LU-22 GENE THERAPY FOR RETINITIS PIGMENTOSA LU EP 15825383.1 Issued
NEI E-162-2016-0-NL-24 GENE THERAPY FOR RETINITIS PIGMENTOSA NL EP 15825383.1 Issued
NEI E-162-2016-0-LV-23 GENE THERAPY FOR RETINITIS PIGMENTOSA LV EP 15825383.1 Issued
NEI E-162-2016-0-TR-27 GENE THERAPY FOR RETINITIS PIGMENTOSA TR EP 15825383.1 Issued
NEI E-162-2016-0-GB-19 GENE THERAPY FOR RETINITIS PIGMENTOSA GB EP 15825383.1 Issued
NEI E-162-2016-0-FI-17 GENE THERAPY FOR RETINITIS PIGMENTOSA FI EP 15825383.1 Issued
NEI E-162-2016-0-DE-13 GENE THERAPY FOR RETINITIS PIGMENTOSA DE EP 15825383.1 Issued
NEI E-162-2016-0-FR-18 GENE THERAPY FOR RETINITIS PIGMENTOSA FR EP 15825383.1 Issued
NEI E-162-2016-0-GR-29 GENE THERAPY FOR RETINITIS PIGMENTOSA GR EP 15825383.1 Issued
NEI E-162-2016-0-IS-20 GENE THERAPY FOR RETINITIS PIGMENTOSA IS EP 15825383.1 Issued
NEI E-162-2016-0-HU-30 GENE THERAPY FOR RETINITIS PIGMENTOSA HU EP 15825383.1 Issued
NEI E-162-2016-0-IT-21 GENE THERAPY FOR RETINITIS PIGMENTOSA IT EP 15825383.1 Issued
NEI E-162-2016-0-BE-11 GENE THERAPY FOR RETINITIS PIGMENTOSA BE EP 15825383.1 Issued
NEI E-162-2016-0-BG-12 GENE THERAPY FOR RETINITIS PIGMENTOSA BG EP 15825383.1 Issued
NEI E-162-2016-0-JP-06 GENE THERAPY FOR RETINITIS PIGMENTOSA JP National Stage 2017-525514 Issued
NEI E-162-2016-0-US-07 Abbreviated Version Of RPGR Is Effective In Gene Replacement Therapy US National Stage 15/328,617 10314924 Issued PDF
NIAID E-285-2002-0-US-25 LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE US DIV 14/802,168 9382302 Expired PDF
NEI E-162-2016-0-PCT-02 GENE THERAPY FOR RETINITIS PIGMENTOSA PCT PCT PCT/US2015/040866 Expired
NCI E-245-2014-0-PCT-02 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses PCT PCT PCT/US15/040922 Expired
NIAID E-173-2014-0-PCT-02 REDUCING CXCR4 EXPRESSION AND/OR FUNCTION TO ENHANCE ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS PCT PCT PCT/US2015/040954 Expired
NCI E-245-2014-0-US-14 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses US National Stage 15/326,011 Abandoned
NEI E-162-2016-0-EP-10 GENE THERAPY FOR RETINITIS PIGMENTOSA EP DIV 20199208.8 Pending
NCI E-245-2014-0-EP-06 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses EP National Stage 15821743.0 Abandoned
NCI E-245-2014-0-JP-09 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses JP National Stage 2017-502693 Pending
NCI E-245-2014-0-MX-11 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses MX National Stage MX/a/2017/000836 Pending
NEI E-162-2016-0-CN-03 GENE THERAPY FOR RETINITIS PIGMENTOSA CN National Stage 2015800515123 Pending
NCI E-245-2014-0-CA-04 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses CA National Stage 2955432 Abandoned
NCI E-245-2014-0-CN-05 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses CN National Stage 201580038799.6 Pending
NCI E-245-2014-0-AU-03 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses AU National Stage 2015289449 Abandoned
NCI E-245-2014-0-IL-07 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses IL National Stage 249671 Pending
NCI E-245-2014-0-IN-08 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses IN National Stage 201717003787 Pending
NCI E-245-2014-0-SG-13 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses SG National Stage 11201700090R Pending
NCI E-245-2014-0-KR-10 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses KR National Stage 10-2017-7000999 Pending
NIAID E-133-2012-0-US-03 Attenuated Chlamydia Vaccine US National Stage 14/761,520 10258682 Issued PDF
NICHD E-016-2013-2-CN-02 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth CN National Stage 201380070622.5 Issued
NCI E-201-2012-0-CN-06 Methods of Treating Patients Infected with HIV and HTLV CN National Stage 201380070484.0 Abandoned
NCATS E-208-2014-0-US-03 Compositions and Methods for Inhibiting BMP US National Stage 15/326,262 10513521 Issued PDF
NHGRI E-020-2003-1-US-13 LYMA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS US CON 14/799,532 Abandoned
NIA E-203-2006-3-US-03 Methods Of Screening For Cell Proliferation Or Neoplastic Disorders US DIV 14/799,388 Abandoned
NCATS E-208-2014-0-PCT-02 Compositions and Methods for Inhibiting BMP PCT PCT PCT/US2015/040366 Expired
NIDDK E-284-2008-0-AU-15 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists AU DIV 2015204281 Issued
NEI E-192-2014-1-CA-04 Surgical Tool and Method for Ocular Tissue Transplantation CA National Stage 2954762 Issued
NEI E-192-2014-1-DK-01 Surgical Tool and Method for Ocular Tissue Transplantation DK EP 15741462.4 Issued
NEI E-192-2014-1-NL-01 Surgical Tool and Method for Ocular Tissue Transplantation NL EP 15741462.4 Issued
NEI E-192-2014-1-SE-01 Surgical Tool and Method for Ocular Tissue Transplantation SE EP 15741462.4 Issued
NEI E-192-2014-1-ES-01 Surgical Tool and Method for Ocular Tissue Transplantation ES EP 15741462.4 Issued
NEI E-192-2014-1-IE-01 Surgical Tool and Method for Ocular Tissue Transplantation IE EP 15741462.4 Issued